Various

Analyst Upgrades and Downgrades For the Week of December 16th

Analyst upgrades, downgrades, and more

By Justin Nugent · December 16, 2024

Analyst Upgrades and Downgrades For the Week of December 16th

Upgrades (Dec 20, 2024):

Affirm (AFRM): JMP Securities – Market Perform >> Market Outperform, PT: $78
Ares Management (ARES): Keefe Bruyette – Market Perform >> Outperform, PT: $166 >> $202
Atmos Energy (ATO): Argus – Hold >> Buy, PT: $150
BlackBerry (BB): TD Securities – Hold >> Buy, PT: $4
Brookline Bancorp (BRKL): Raymond James – Market Perform >> Strong Buy, PT: $16
Camden National Corp. (CAC): Raymond James – Market Perform >> Outperform, PT: $50
DoorDash (DASH): Argus – Hold >> Buy
Brinker (EAT): Morgan Stanley – Underweight >> Equal-Weight, PT: $70 >> $115
Evercore (EVR): Keefe Bruyette – Market Perform >> Outperform, PT: $269 >> $339
FedEx (FDX): Loop Capital – Hold >> Buy, PT: $288 >> $365
FREYR Battery (FREY): BTIG Research – Neutral >> Buy, PT: $4
Federal Realty (FRT): JP Morgan – Neutral >> Overweight, PT: $122 >> $125
Innoviz Technologies (INVZ): Rosenblatt – Neutral >> Buy, PT: $4
Johnson Controls (JCI): Argus – Hold >> Buy, PT: $88
Kilroy Realty (KRC): JP Morgan – Neutral >> Overweight, PT: $45 >> $49
Moelis (MC): Keefe Bruyette – Market Perform >> Outperform, PT: $71 >> $86
Tradeweb Markets (TW): Keefe Bruyette – Market Perform >> Outperform, PT: $143 >> $150
Willis Towers Watson (WTW): Jefferies – Hold >> Buy, PT: $352 >> $382
Spire (SR): Mizuho – Neutral >> Outperform, PT: $65 >> $76
State Street (STT): JP Morgan – Underweight >> Neutral, PT: $95

Downgrades (Dec 20, 2024):

Biogen (BIIB): BMO Capital Markets – Outperform >> Market Perform, PT: $230 >> $164
Cabaletta Bio (CABA): Evercore ISI – Outperform >> In-line, PT: $15 >> $6
Exelixis (EXEL): BMO Capital Markets – Outperform >> Market Perform, PT: $36 >> $40
HOOKIPA Pharma (HOOK): RBC Capital Mkts – Outperform >> Sector Perform, PT: $48 >> $2
Healthcare Realty (HR): JP Morgan – Overweight >> Neutral, PT: $19
Kimco Realty (KIM): JP Morgan – Overweight >> Neutral, PT: $26
Lazard (LAZ): Keefe Bruyette – Outperform >> Market Perform, PT: $65 >> $57
Lennar (LEN): BTIG Research – Buy >> Neutral
Lineage (LINE): JP Morgan – Overweight >> Neutral, PT: $78 >> $75
Lamb Weston (LW): Citigroup – Buy >> Neutral, PT: $90 >> $68
Merck (MRK): BMO Capital Markets – Outperform >> Market Perform, PT: $136 >> $105
NIKE (NKE): Telsey Advisory Group – Outperform >> Market Perform, PT: $80
PBF Energy (PBF): TD Cowen – Hold >> Sell, PT: $27 >> $20
RxSight (RXST): Stifel – Buy >> Hold, PT: $65 >> $40
Spero Therapeutics (SPRO): Evercore ISI – Outperform >> In-line, PT: $5
Oracle (ORCL): Monness Crespi & Hardt – Neutral >> Sell, PT: $130
Innovative Industrial Properties (IIPR):
- Compass Point – Buy >> Neutral, PT: $125 >> $78
- Piper Sandler – Neutral >> Underweight, PT: $118 >> $70
Halliburton (HAL): Griffin Securities – Buy >> Neutral
SLB (SLB): Griffin Securities – Buy >> Neutral
Softbank (SFTBY): Jefferies – Buy >> Hold

Coverage Initiated (Dec 20, 2024):

Applied Digital Corporation (APLD): Cantor Fitzgerald – Overweight, PT: $15
California Resources Corp (CRC): JP Morgan – Neutral, PT: $63
Definitive Healthcare (DH): Stephens – Equal-Weight, PT: $5
Dianthus Therapeutics (DNTH): TD Cowen – Buy
Doximity (DOCS): Stephens – Equal-Weight, PT: $55
Fair Isaac (FICO): JP Morgan – Neutral, PT: $2150
Financial Inst. (FISI): Piper Sandler – Overweight, PT: $33
IQVIA (IQV): Stephens – Overweight, PT: $250
IREN Limited (IREN): BTIG Research – Buy, PT: $33
LCNB (LCNB): Hovde Group – Market Perform, PT: $16.25
Liquidia Technologies (LQDA): Wells Fargo – Overweight, PT: $20
Mannkind (MNKD): Wells Fargo – Overweight, PT: $9
MindMed (MNMD): Chardan Capital Markets – Buy, PT: $20
Motorcar Parts of America (MPAA): Cantor Fitzgerald – Overweight, PT: $14
Northrim Bank (NRIM): Hovde Group – Outperform, PT: $96.5
OptimizeRx (OPRX): Stephens – Equal-Weight, PT: $5.5
Vaxcyte (PCVX): Goldman – Buy, PT: $135
PennantPark Floating Rate Capital (PFLT): Raymond James – Market Perform
Prothena (PRTA): Chardan Capital Markets – Buy, PT: $40
Reddit (RDDT): Guggenheim – Buy, PT: $210
Avidity Biosciences (RNA): H.C. Wainwright – Buy, PT: $72
Rhythm Pharmaceuticals (RYTM): Oppenheimer – Outperform, PT: $76
S&P Global (SPGI): Citigroup – Buy, PT: $600
Stoke Therapeutics (STOK): Chardan Capital Markets – Buy, PT: $24
Savara (SVRA): Wells Fargo – Overweight, PT: $8
Veeva Systems (VEEV): Stephens – Overweight, PT: $280
Valvoline (VVV): Stifel – Hold, PT: $42
Moody’s (MCO): Citigroup – Buy, PT: $565
AirJoule Technologies Corp. (AIRJ): H.C. Wainwright – Buy, PT: $12
Cognex (CGNX): Cantor Fitzgerald – Overweight, PT: $49
Xometry (XMTR): Wedbush – Outperform, PT: $48
Rigetti Computing (RGTI): Craig Hallum – Buy, PT: $12
Vital Farms (VITL): Craig Hallum – Buy, PT: $50

Upgrades

Banco BBVA Argentina S.A. (BBAR) – Morgan Stanley: Underweight >> Overweight | Price Target: $27
Banco Macro (BMA) – Morgan Stanley: Underweight >> Overweight | Price Target: $12.5
Peabody Energy (BTU) – BMO Capital Markets: Market Perform >> Outperform | Price Target: $26
CBRE Group (CBRE) – JP Morgan: Neutral >> Overweight | Price Target: $120 >> $163
ConocoPhillips (COP) – Mizuho: Neutral >> Outperform | Price Target: $132 >> $134
Comstock (CRK) – Mizuho: Underperform >> Neutral | Price Target: $10 >> $18
Equifax (EFX) – Exane BNP Paribas: Neutral >> Outperform | Price Target: $305
EQT Corp. (EQT) – Mizuho: Neutral >> Outperform | Price Target: $48 >> $57
Grupo Financiero Galicia (GGAL) – Morgan Stanley: Underweight >> Overweight | Price Target: $92
Keysight (KEYS) – JP Morgan: Neutral >> Overweight | Price Target: $170 >> $200
LifeStance Health Group (LFST) – Goldman: Neutral >> Buy | Price Target: $10
Macy’s (M) – Gordon Haskett: Hold >> Buy | Price Target: $20
NetApp (NTAP) – JP Morgan: Neutral >> Overweight | Price Target: $160
Okta (OKTA) – JP Morgan: Neutral >> Overweight | Price Target: $100
Grupo Supervielle (SUPV) – Morgan Stanley: Underweight >> Overweight | Price Target: $19
Teradyne (TER) – JP Morgan: Neutral >> Overweight | Price Target: $145 >> $158
Trimble (TRMB) – Wolfe Research: Peer Perform >> Outperform | Price Target: $90
Zymeworks (ZYME) – JP Morgan: Neutral >> Overweight | Price Target: $18
Ametek (AME) – BofA Securities: Neutral >> Buy | Price Target: $195 >> $225
Denali Therapeutics (DNLI) – Stifel: Hold >> Buy | Price Target: $37
U.S. Physical Therapy (USPH) – BofA Securities: Neutral >> Buy | Price Target: $100 >> $115
Bristol-Myers (BMY) – Jefferies: Hold >> Buy | Price Target: $70
Concentra Group Holdings Parent (CON) – BofA Securities: Neutral >> Buy | Price Target: $24
Advanced Energy (AEIS) – BofA Securities: Neutral >> Buy | Price Target: $140
Ambarella (AMBA) – BofA Securities: Underperform >> Neutral | Price Target: $80
Edwards Lifesciences (EW) – BofA Securities: Neutral >> Buy
AT&T (T) – Morgan Stanley: Equal-Weight >> Overweight | Price Target: $19 >> $28

Downgrades

Adient (ADNT) – Wells Fargo: Overweight >> Equal Weight | Price Target: $27 >> $20
TopBuild (BLD) – Evercore ISI: Outperform >> In-line | Price Target: $443 >> $381
CNX Resources (CNX) – Mizuho: Neutral >> Underperform | Price Target: $33 >> $38
Eagle Materials (EXP) – Jefferies: Buy >> Hold | Price Target: $330 >> $310
Ford Motor (F) – Jefferies: Hold >> Underperform | Price Target: $12 >> $9
Installed Building Products (IBP) – Evercore ISI: Outperform >> Underperform | Price Target: $238 >> $206
Keros Therapeutics (KROS) – Guggenheim: Buy >> Neutral
Masco (MAS) – Jefferies: Buy >> Hold | Price Target: $96 >> $89
Microchip (MCHP) – BofA Securities: Neutral >> Underperform | Price Target: $80 >> $65
Netflix (NFLX) – Loop Capital: Buy >> Hold | Price Target: $800 >> $950
Northern Oil & Gas (NOG) – Mizuho: Outperform >> Neutral | Price Target: $47
Par Pacific (PARR) – Mizuho: Outperform >> Neutral | Price Target: $26 >> $22
PBF Energy (PBF) – Mizuho: Neutral >> Underperform | Price Target: $33 >> $31
Robert Half (RHI) – Exane BNP Paribas: Outperform >> Underperform | Price Target: $64
Summit Materials (SUM) – Jefferies: Buy >> Hold | Price Target: $58 >> $52.5
Tenet Healthcare (THC) – Goldman: Buy >> Neutral | Price Target: $196 >> $140
Universal Health (UHS) – Goldman: Buy >> Neutral | Price Target: $228 >> $198
Alector (ALEC) – Stifel: Buy >> Hold | Price Target: $4
Biogen (BIIB) – Stifel: Buy >> Hold | Price Target: $175
Editas Medicine (EDIT) – JP Morgan: Neutral >> Underweight
Brown-Forman (BF.B) – Truist: Buy >> Hold | Price Target: $50 >> $45
Logitech Int’l SA (LOGI) – BofA Securities: Buy >> Neutral | Price Target: $114 >> $92
Amer Sports (AS) – HSBC Securities: Buy >> Hold | Price Target: $30
Suncor Energy (SU) – Morgan Stanley: Overweight >> Equal-Weight
Match Group (MTCH) – New Street: Buy >> Neutral
MongoDB (MDB) – Monness Crespi & Hardt: Neutral >> Sell | Price Target: $220
Credicorp LTD (BAP) – BofA Securities: Buy >> Neutral
Banco Santander Chile (BSAC) – BofA Securities: Buy >> Neutral
Comcast (CMCSA) – Morgan Stanley: Overweight >> Equal-Weight | Price Target: $48 >> $45
PepGen (PEPG) – BofA Securities: Neutral >> Underperform | Price Target: $3

Coverage Initiated

Addus HomeCare (ADUS) – JMP Securities: Mkt Outperform | Price Target: $150
Grindr (GRND) – Goldman: Buy | Price Target: $20
U.S. Physical Therapy (USPH) – JMP Securities: Mkt Outperform | Price Target: $113
Waldencast plc (WALD) – TD Cowen: Hold | Price Target: $4.3
ConocoPhillips (COP) – Morgan Stanley: Overweight | Price Target: $128
Benitec Biopharma (BNTC) – H.C. Wainwright: Buy | Price Target: $28
Zenas Biopharma (ZBIO) – H.C. Wainwright: Buy | Price Target: $30
Colliers (CIGI) – JP Morgan: Neutral | Price Target: $167
Vishay (VSH) – JP Morgan: Neutral | Price Target: $19
Surgery Partners (SGRY) – BofA Securities: Buy | Price Target: $30
Golden Entertainment (GDEN) – Wells Fargo: Overweight | Price Target: $38